Vitamin K2 and Thyroid: Is There a Real Connection?
Vitamin K2 is essential for activating calcium-binding proteins involved in bone and cardiovascular health. There is no direct randomized trial of vitamin K2 for hypothyroidism or Hashimoto's, and no thyroid society recommends it for thyroid disease. K2 is reasonable for general adult health, but don't expect it to change TSH or antibodies.
What vitamin K2 actually does
Vitamin K exists in two main forms [C1][C2]:
- K1 (phylloquinone): found in leafy greens; supports blood clotting
- K2 (menaquinones, MK-4, MK-7): found in fermented foods, animal products, and some bacterial sources; activates calcium-binding proteins including osteocalcin (bone) and matrix Gla protein (cardiovascular)
The 2017 Schwalfenberg review describes K2's role in directing calcium to bones and away from arteries, with evidence supporting cardiovascular and bone health [C3]. The 2013 Beulens review covered the broader menaquinone literature with the same conclusions [C5].
What's notably absent: any direct evidence that K2 affects thyroid hormone production, TSH, free T4, or thyroid autoimmunity in humans.
Where the "K2 and thyroid" claim comes from
Two arguments link K2 to thyroid health:
- The vitamin D pairing. K2 is commonly bundled with vitamin D3 in supplements because vitamin D increases calcium absorption and K2 helps direct that calcium to bones rather than arteries [C3][C5]. Many Hashimoto's patients take vitamin D, so K2 gets bundled in.
- General osteoporosis risk in hypothyroidism. Long-term over-replacement with levothyroxine can reduce bone density, and K2 supports bone health [C1][C3].
Both arguments are about general health adjacent to thyroid disease, not thyroid function itself.
What the evidence does (and doesn't) show
The NIH ODS Vitamin K fact sheet does not list any thyroid indication for vitamin K [C1]. The 2014 ATA hypothyroidism guidelines do not include vitamin K2 among recommended interventions [C6]. The American Thyroid Association's patient guidance for hypothyroidism doesn't mention K2 [C4].
What K2 does have evidence for [C3][C5]:
- Modest improvement in bone density and reduced fracture risk in postmenopausal women
- Reduced arterial calcification in some cohorts
- A role in coagulation balance (less than K1)
No human trial has tested whether K2 lowers TSH, reduces TPO antibodies, or improves Hashimoto's outcomes.
Practical scenarios where K2 may matter
On long-term levothyroxine with normal TSH: No specific reason for K2 unless your overall bone health argues for it.
On levothyroxine with suppressed TSH (e.g., post-thyroid-cancer): Long-term TSH suppression carries bone density risk, and adequate K and calcium intake supports skeletal health [C3]. Discuss bone density monitoring and supplementation with your endocrinologist.
Postmenopausal women with Hashimoto's: General osteoporosis prevention applies; K2 is one of many tools (calcium, vitamin D, weight-bearing exercise) [C3][C5].
Vegan diet: Most dietary K2 comes from animal products (dairy, eggs, liver) and natto (fermented soybeans). Vegan diets with no natto are low in K2. K1 from greens is plentiful, but conversion to K2 in the body is limited [C1][C5].
On warfarin (Coumadin): Vitamin K interacts with warfarin's anticoagulation. Don't start K2 supplementation while on warfarin without coordinating with your prescriber — the dose may need adjustment [C1].
Practical guidelines
- K2 isn't a thyroid intervention. Don't expect it to change TSH or antibody levels [C4][C6].
- For general health, K2 from food works. Natto (the densest source), aged cheese, egg yolks, grass-fed dairy, and chicken liver provide menaquinones [C1][C7].
- K2/D3 combinations are reasonable if you supplement D3. Especially if calcium intake is also adequate, the K2 helps direct calcium appropriately [C3].
- Dose, if supplementing: 90–180 mcg/day MK-7 is typical. Well within safety margins; vitamin K has no established Upper Limit due to low toxicity [C1].
- Warfarin users: coordinate with your prescriber [C1].
- Separate from levothyroxine by 30–60 minutes to respect the empty-stomach window, though no direct interaction is documented [C6].
Frequently asked questions
Will vitamin K2 help my Hashimoto's? No randomized trial supports this [C4][C6]. K2 has evidence for bone and cardiovascular health, not thyroid function.
Should I take K2 with my vitamin D for Hashimoto's? Reasonable for general health, especially if your dietary K2 is low. It won't change Hashimoto's outcomes but supports calcium handling [C3].
Is MK-7 better than MK-4? MK-7 has a longer half-life and may stay in the bloodstream longer; MK-4 is more concentrated in tissues. Both forms have evidence in bone and cardiovascular studies. Most supplements use MK-7 [C3][C5].
How much vitamin K2 do I need? There is no Recommended Dietary Allowance specifically for K2; the general Adequate Intake for total vitamin K is 120 mcg/day for men and 90 mcg/day for women [C1]. Supplemental K2 trials commonly use 90–180 mcg/day MK-7 [C3].
Is vitamin K2 safe with levothyroxine? No direct interaction is documented, but separate by 30–60 minutes from morning levothyroxine to respect the absorption window [C6].
Bottom line
Vitamin K2 has real evidence for bone and cardiovascular health [C3][C5], but no direct evidence for hypothyroidism or Hashimoto's [C4][C6]. The K2-thyroid pairing on supplement labels is about adjacent health goals (especially calcium handling when pairing with vitamin D), not thyroid function itself. If your diet is low in fermented foods, dairy, eggs, or liver — particularly on a vegan diet without natto — supplementing K2 is reasonable for general health. Just don't expect it to change your thyroid labs or symptoms.
Sources
- [C1] NIH Office of Dietary Supplements. Vitamin K — Fact Sheet for Health Professionals. ods.od.nih.gov
- [C2] Linus Pauling Institute. Vitamin K. lpi.oregonstate.edu
- [C3] Schwalfenberg GK. Vitamins K1 and K2: The Emerging Group of Vitamins Required for Human Health. J Nutr Metab. 2017;2017:6254836. PubMed: 28698808
- [C4] American Thyroid Association. Hypothyroidism — Patient Information. thyroid.org
- [C5] Beulens JW, Booth SL, van den Heuvel EG, Stoecklin E, Baka A, Vermeer C. The role of menaquinones (vitamin K2) in human health. Br J Nutr. 2013;110(8):1357–1368. PubMed: 23590754
- [C6] Jonklaas J et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670–1751. PubMed: 25266247
- [C7] Harvard T.H. Chan School of Public Health. The Nutrition Source: Vitamin K. nutritionsource.hsph.harvard.edu
For educational purposes only. Not medical advice. Always consult your healthcare provider.
Related reading
Continue with Thyra context
Educational resources to help you understand food, routines, and tracking. Not medical advice or treatment recommendations.
Sources
- ANIH Office of Dietary Supplements — Vitamin K Fact Sheet· 2024 · government-fact-sheet
- BLinus Pauling Institute — Vitamin K· 2024 · university-reference
- ASchwalfenberg GK 2017 — Vitamins K1 and K2: the emerging group of vitamins required for human health· 2017 · narrative-review
- AAmerican Thyroid Association — Hypothyroidism patient brochure· 2024 · specialty-society-review
- ABeulens JW et al. 2013 — The role of menaquinones (vitamin K2) in human health· 2013 · narrative-review
- AJonklaas J et al. 2014 — ATA hypothyroidism treatment guidelines· 2014 · clinical-practice-guideline
- BHarvard T.H. Chan School of Public Health — Vitamin K· 2024 · university-reference